Global Oxytocin Testing Kits Market Size, Share, and COVID-19 Impact Analysis, By Test Kits (ELISA Kits, RIA Kits, CLIA Kits, LC-MS/MS Kits, Rapid POC Kits, and Biosensor/Multiplex Kits), By Application (Obstetrics and Reproductive Health, Neuropsychiatric and Behavioural Research, Endocrinology and Metabolic Disorders, Pharma/Biotech R&D, and Veterinary Applications), By End Users (Hospitals, Maternity Centers, Pharmaceutical Companies, Diagnostic Laboratories, Academic & Research Institutions, and Veterinary Hospitals & Clinics), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035

Global Oxytocin Testing Kits Market Size Insights Forecasts to 2035

• The Global Oxytocin Testing Kits Market Size Was Estimated at USD 696.5 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 6.05% from 2025 to 2035
• The Worldwide Oxytocin Testing Kits Market Size is Expected to Reach USD 1329.5 Million by 2035
• Asia Pacific is expected to grow the fastest during the forecast period.

According to a research report published by Spherical Insights and Consulting, the Global Oxytocin Testing Kits Market Size was worth around USD 696.5 Million in 2024 and is Predicted to Grow to around USD 1329.5 Million by 2035 with a Compound Annual Growth Rate (CAGR) of 6.05% from 2025 and 2035. The market for oxytocin testing kits has a number of opportunities to grow due to the emergence of oxytocin assay techniques, along with the surging advancement in human oxytocin measurement.

Market Overview

The Global Oxytocin Testing Kits Market industry is a specialized, growing sector focused on tools for detecting and measuring oxytocin levels, primarily used to monitor oxytocin quality/potency and in research settings. The segment is driven by the need for high-quality, stable medication in obstetrics to prevent postpartum haemorrhage (PPH). These kits are being used for labor induction, augmentation, and postpartum haemorrhage (PPH) prevention, fueled by an increasing number of hospital births, rising incidence of pregnancy complications.    

Innovation and market expansion are anticipated as a result of major players' growing investment in the production of high-quality oxytocin for low-resource settings. Key innovations, like aptamer-based electrochemical assays, paper-microfluidics & colourimetric detection, smartphone-linked immunosensing, and improved salivary assays, are driving a huge surge in the global oxytocin testing kits market.    

Report Coverage

This research report categorizes the Oxytocin Testing Kits Market based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the oxytocin testing kits market. Recent market developments and competitive strategies such as expansion, type launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Oxytocin Testing Kits Market.  

Driving Factors

Use of oxytocin assays for postpartum and psychiatric screening is driving the market demand for Oxytocin Testing Kits Market. Advancements in immunoassay technologies like ELISA and chemiluminescent assays, along with an increasing need for accurate hormonal assessments, also play an important role in the oxytocin testing kits market. There is ongoing research on oxytocin’s role in building social bonds, stress, and mental health, which requires assessing its levels, thus enhancing the market demand.       

Restraining Factors

The Oxytocin Testing Kits Market is restricted by data discrepancies due to a lack of standardized protocols for sample collection and handling. Further, the increased cost of advanced testing kits, as well as cost and supply chain issues, are challenging the market growth.

Market Segmentation

The oxytocin testing kits market share is classified into test kits, application, and end users.   

• The ELISA kits segment accounted for about 57.0% share in 2024 and is anticipated to grow at a significant CAGR during the projected period.

Based on the test kits, the Oxytocin Testing Kits Market is divided into ELISA kits, RIA kits, CLIA kits, LC-MS/MS kits, rapid POC kits, and biosensor/multiplex kits. Among these, the ELISA kits segment accounted for about 57.0% share in 2024 and is anticipated to grow at a significant CAGR during the projected period. Ultra-sensitive measurement, detecting as little as 15pg/ml oxytocin. It is cost effective solutions than LC/MS and faster, easy to use, liquid color-coded reagents and pre-coated plates minimizing errors. Further, their high sensitivity, reproducibility, and ability to quantify oxytocin in complex biological matrices such as plasma, saliva, and cerebrospinal fluid, as well as their increased adoption in clinical and research settings for precise hormonal quantification, are driving the market demand.

• The obstetrics and reproductive health segment dominated the market with the largest share of over 70.0% in 2024 and is projected to grow at a substantial CAGR during the forecast period.

Based on the application, the Oxytocin Testing Kits Market is divided into obstetrics and reproductive health, neuropsychiatric and behavioural research, endocrinology and metabolic disorders, pharma/biotech R&D, and veterinary applications. Among these, the obstetrics and reproductive health segment dominated the market with the largest share of over 70.0% in 2024 and is projected to grow at a substantial CAGR during the forecast period. Oxytocin monitoring is required during labor induction, lactation assessments, and fertility-related evaluations. Oxytocin kits manage inducing or augmenting labor and preventing or managing postpartum hemorrhage (PPH), affecting maternal mortality.     

• The hospitals segment accounted for the largest share of over 38.0% in 2024 and is anticipated to grow at a significant CAGR during the forecast period.

Based on the end users, the Oxytocin Testing Kits Market is divided into hospitals, maternity centers, pharmaceutical companies, diagnostic laboratories, academic & research institutions, and veterinary hospitals & clinics. Among these, the hospitals segment accounted for the largest share of over 38.0% in 2024 and is anticipated to grow at a significant CAGR during the forecast period. In modern hospitals, oxytocin testing is a contraction stress test used for assessing fetal well-being in high-risk pregnancies. The essential role of oxytocin testing kits in labor and delivery care, emergency obstetric interventions, and postpartum monitoring in hospitals is driving the segmental market. 

Regional Segment Analysis of the Oxytocin Testing Kits Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share of the oxytocin testing kits market over the predicted timeframe.

North America is anticipated to hold the largest share of over 50.1% in the Oxytocin Testing Kits Market over the predicted timeframe. The market ecosystem in North America is strong, with major industrial heavyweights well-represented. For instance, Oxytocin ELISA kit from Enzo Life Sciences, Inc. The demand for oxytocin testing kits has been driven by the region's increasing maternal health initiatives, high number of institutional births, and demand for postpartum haemorrhage (PPH) management. The U.S. is leading the North America oxytocin testing kits market, accounting for nearly 43.0% share, driven by increased healthcare spending, increased birth rates (over 3.6 million annual births), and the presence of advanced maternal care infrastructure. 

Asia Pacific is expected to grow at a rapid CAGR of the Oxytocin Testing Kits Market during the forecast period. The Asia Pacific area has a thriving market for oxytocin testing kits due to the region’s higher birth rates, expanding healthcare infrastructure, and awareness surrounding maternal health. Due to their government's public health initiatives supporting funding maternal health programmes, along with an increasing healthcare expenditure on diagnostics, including hormone testing tools, the oxytocin testing kits market is growing. India is leading the regional market, recording the fastest CAGR of about 10.3% during the forecast period, due to the surging development of oxytocin testing kits by the Indian diagnostic brands, with their high use among IVF clinics and imported products in private labs. 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Oxytocin Testing Kits Market, along with a comparative evaluation primarily based on their type of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes type development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Elabscience
• Thermo Fisher Scientific Inc
• Zellx
• Enzo Biochem Inc.
• FUJIFILM Wako Pure Chemical Corporation
• RayBiotech, Inc.
• ELK Biotechnology CO., Ltd.
• Wuhan Fine Biotech Co., Ltd
• Abbexa
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs) 

Recent Development

• In October 2025, Tonix Pharmaceuticals is planning the launch of a Phase 2 clinical trial to test its TNX-2900 nasal spray, containing a specialized form of oxytocin, in children and teens with Prader-Willi syndrome (PWS).  

• In July 2025, RayBiotech launched the Human/Mouse/Rat Oxytocin EIA Kit, optimized for use with serum, plasma, and cell culture media, marking the company’s expansion in the hormone quantification segment.

• In May 2024, FUJIFILM Wako Pure Chemical Corporation announced that operations began utilizing new equipment that triple 1 production capacity of GMP-compliant 2 raw materials for pharmaceutical manufacturing at its Osaka facility, located at 6-1 Takata-cho, Amagasaki City, Hyogo Prefecture, Japan.

• In November 2022, Pune dairies to conduct tests to rule out oxytocin traces in milk. Following the arrest of six dairy farmers in Pune and the adjoining areas for injecting buffaloes with oxytocin to increase their milk-producing capacity, milk federations such as Katraj and Sonai have decided to conduct the necessary tests to rule out any traces of oxytocin in the milk produced by them.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the Oxytocin Testing Kits Market based on the below-mentioned segments:  

Global Oxytocin Testing Kits Market, By Test Kits

• ELISA Kits
• RIA Kits
• CLIA Kits
• LC-MS/MS Kits
• Rapid POC Kits
• Biosensor/Multiplex Kits

Global Oxytocin Testing Kits Market, By Application

• Obstetrics and Reproductive Health
• Neuropsychiatric and Behavioural Research
• Endocrinology and Metabolic Disorders
• Pharma/Biotech R&D
• Veterinary Applications

Global Oxytocin Testing Kits Market, By End Users

• Hospitals
• Maternity Centers
• Pharmaceutical Companies
• Diagnostic Laboratories
• Academic & Research Institutions
• Veterinary Hospitals & Clinics

Global Oxytocin Testing Kits Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico

• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe

• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific

• South America
  • Brazil
  • Argentina
  • Rest of South America

• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa